ESTEVE's 2024 Revenue Grows by 5% as It Pursues Specialized Medicine Goals ESTEVE, the pharmaceutical company, reported a 5% increase in net revenue for 2024, reflecting its commitment to specialized healthcare solutions and global expansion.

ESTEVE's 2024 Revenue Grows by 5% as It Pursues Specialized Medicine Goals #Spain #Barcelona #revenue_growth #ESTEVE #Pharmaceutical_Company